Government Owned Invention Available for License: Human Antibodies Targeting Beneficial Viral Peptide in Liver Cancer
Official abstract: The National Cancer Institute (NCI) seeks research co- development partners and/or licensees to develop a collection of anti- CE1 antibodies for liver cancer treatment.